Improving Medication Management in World Trade Center Responders

Conditions

• Polypharmacy

Eligibility Criteria

Sex

ALL

Age

50 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Educational brochure for deprescribing — OTHER
  Study participant will be provided information (i.e., educational brochure) about one of the five medication classes participants may be taking that are known to have potential side effects for older adults: proton pump inhibitors (PPIs), benzodiazepine (BZs) and non-benzodiazepine sedative hypnotics ("Z-drugs"), first-generation antihistamines (FGA), and skeletal muscle relaxants (SMR) to determine their necessity.

Study Details

By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.

Key Dates

Start date

Apr 8, 2025

Status verified

Jun 2025

Primary completion

Jun 30, 2026

Completion

Jun 30, 2026

Study Design

Enrollment

50 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Experimental: World Trade Center (WTC) Responders
  World Trade Center (WTC) rescue and recovery workers (responders).

Primary Outcome Measure

Brief Medication Questionnaire 2 (BMQ2) [ Time Frame: 6 months after study enrollment ]

Central Contacts

• Patricia Kim
  212-241-9370
  [email protected]

Locations (1)

Find similar trials in New York, NY